This was confirmed also in our study, where the achievement of the mitotane target levels represented an independent and, together with Ki67 index, the strongest predictor of tumor recurrence or progression both in patients after radical resection and in those with not completely resected, recurrent or advanced ACC. This evidence concerns the gene MKI67 and adrenal cortex carcinoma.